Ayurvedic Approach to Recurrent Abortions: A Pilot Study on Garbhasrava Management

Recurrent spontaneous abortion (RSA), a distressing condition affecting approximately 1%-2% of women of reproductive age, often lacks a definitive etiology despite extensive investigations. In the realm of Ayurvedic medicine, recurrent miscarriage can be correlated with "Garbhasrava" and "Garbhapata," conditions attributed to Doshic imbalances, particularly involving Vata. This pilot clinical study aimed to evaluate the efficacy of an Ayurvedic polyherbal formulation, TAB-GM, in managing unexplained recurrent abortions. This pilot study aimed to evaluate the role of an Ayurvedic formulation, TAB-GM, in sustaining pregnancy among women with a history of RSA. The study included 9 pregnant women aged 20–35 years, each with a history of two or more consecutive unexplained miscarriages. TAB-GM, a proprietary polyherbal formulation with documented Garbhasthapana, Raktavardhaka, and Rasayana effects, was administered orally at a dose of 500 mg twice daily from confirmation of pregnancy until completion of the fourth month of gestation. Primary outcomes assessed were continuation of pregnancy beyond 20 weeks, maternal health, and safety of the formulation. The results indicated that all 9 participants successfully carried their pregnancies beyond 20 weeks without complications or miscarriage recurrence. The intervention was well-tolerated, with no adverse drug reactions or deviations in hematological and biochemical parameters. These preliminary findings suggest that TAB-GM may be a safe and potentially effective supportive therapy for pregnancy sustenance in women with unexplained RPL. However, further large-scale, randomized controlled trials are needed to validate these outcomes and establish robust clinical guidelines. This study underlines the value of Ayurvedic approaches in managing complex reproductive challenges.